Premium
Risk of alanine aminotransferase flare‐up among asymptomatic hepatitis C virus RNA carriers: A 10‐year follow‐up study
Author(s) -
Tsuji Kenichirou,
Yamasaki Kazumi,
Yamanishi Mikio,
Kawakami Masuhiro,
Shirahama Satoshi
Publication year - 2001
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1046/j.1440-1746.2001.02474.x
Subject(s) - medicine , asymptomatic , alanine aminotransferase , asymptomatic carrier , alanine transaminase , virology , hepatitis a virus , aspartate aminotransferases , hepatitis c virus , viral hepatitis , gastroenterology , virus , immunology
Aims: The aim of this study was to determine the cumulative rate of flare‐up of serum alanine aminotransferase (ALT) level during a 10‐year follow‐up period, and characterize the clinical, virologic features in 120 hepatitis C virus (HCV) RNA‐positive asymptomatic carriers with persistently normal ALT levels for 6 months. Results: All flare‐up cases occurred during the first 5 years of the present study, 27.4% of carriers showed ALT flare‐up during this period, but none in the second half of the study. Multivariate analysis showed that C100–3 antibody (Ab) and anti‐human T cell leukemia virus (HTLV)‐I Ab were two independent and significant predictors of ALT flare‐up in hepatitis C virus (HCV) RNA asymptomatic carriers ( P = 0.04, P = 0.03, respectively). Liver biopsy was performed in 44 patients (11 with flare‐up of ALT level, whereas 33 had normal ALT levels). Histological features of chronic hepatitis with lymphoid infiltration in the portal tracts were commonly observed in all specimens, and no differences were noted between the flare‐up ALT group and the persistently normal ALT group. Conclusions: Our results indicated that flare‐up of ALT levels in asymptomatic HCV‐RNA carriers with normal ALT levels occurs during the first 5 years of diagnosis, and that the presence of C100–3 and anti‐HTLV‐I antibodies are good predictors of a transient rise in ALT.